Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022.

Chavez Ortiz JL, Griffin I, Kazakova SV, et al. Transfusion‐related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014–2022. Transfusion. 2024;64(4):627-637. doi:10.1111/trf.17775.

Save
Print
March 27, 2024
Chavez Ortiz JL, Griffin I, Kazakova SV, et al. Transfusion. 2024;64(4):627-637.
View more articles from the same authors.

Blood transfusion errors, while rare, can be severe and potentially fatal. This study used eight years of transfusion-related errors reported to the National Healthcare Safety Network (NHSN) Hemovigilance Module to quantify errors, adverse events, and blood wastage. Most reported errors were near misses and occurred during sample collection, sample handling, and product administration. Error reporting declined significantly during the study period; the researchers state efforts are underway to decrease reporting burden and increase participation in the NHSN Hemovigilance Module.

Save
Print
Cite
Citation

Chavez Ortiz JL, Griffin I, Kazakova SV, et al. Transfusion‐related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014–2022. Transfusion. 2024;64(4):627-637. doi:10.1111/trf.17775.